Salute e Benessere
Pompe disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Pompe disease symptoms are caused by missing or insufficient amounts of an enzyme called acid alpha-glucosidase (GAA). Although, there is currently no cure, different Pompe disease treatment options can help to ease Pompe disease symptoms.
Most patients require supportive therapy to address the Pompe disease symptoms that include respiratory and cardiac problems, physical disability, and difficulty swallowing. Some patients may require a mechanical ventilator during respiratory infections or at night. Physical and occupational therapy can improve patients' muscle strength and help them to learn to use canes or walkers if necessary. Speech therapy and usage of feeding tubes are some of the other components. Prior to the arrival of Enzyme replacement therapy (ERT) in 2006, patients were primarily dependent on Supportive Treatment comprising of respiratory support, ambulatory support, physiotherapy and/or dietary treatment.
The increasing awareness of the Pompe disease assisted by organizational support along with the high prices of Enzyme Replacement therapies (and expanded approvals) is expected to fuel the Pompe disease market size during the forecasted period of 2019-2028.
Pompe disease
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Related reports:
Shruti Thakur
info@delveinsight.com
+91-9650213330